Thursday Endocrine journal club - Shared screen with speaker view
Who can see your viewing activity?
Its in the methods section base on ROC for testo in diabetes / no diabetes
For the semuglitide study, the effect on weight loss was ~ 15% from baseline compared to 2% with placebo at week 68 from starting, greater reduction in waist circumference ( -13.4 vs -4.13
This is in adjunct with lifestyle
thank you hessa
HbA1c reduction of -0.34 in excess of placebo in non DM
well done Hessa